These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 15627031)
1. Control of viral rebound through therapeutic immunization with DermaVir. Lisziewicz J; Trocio J; Xu J; Whitman L; Ryder A; Bakare N; Lewis MG; Wagner W; Pistorio A; Arya S; Lori F AIDS; 2005 Jan; 19(1):35-43. PubMed ID: 15627031 [TBL] [Abstract][Full Text] [Related]
2. Two-Year Follow-Up of Macaques Developing Intermittent Control of the Human Immunodeficiency Virus Homolog Simian Immunodeficiency Virus SIVmac251 in the Chronic Phase of Infection. Shytaj IL; Nickel G; Arts E; Farrell N; Biffoni M; Pal R; Chung HK; LaBranche C; Montefiori D; Vargas-Inchaustegui D; Robert-Guroff M; Lewis MG; Sacha JB; Palamara AT; Savarino A J Virol; 2015 Aug; 89(15):7521-35. PubMed ID: 25972547 [TBL] [Abstract][Full Text] [Related]
3. Resting CD4+ T lymphocytes but not thymocytes provide a latent viral reservoir in a simian immunodeficiency virus-Macaca nemestrina model of human immunodeficiency virus type 1-infected patients on highly active antiretroviral therapy. Shen A; Zink MC; Mankowski JL; Chadwick K; Margolick JB; Carruth LM; Li M; Clements JE; Siliciano RF J Virol; 2003 Apr; 77(8):4938-49. PubMed ID: 12663799 [TBL] [Abstract][Full Text] [Related]
4. Initiation of antiretroviral therapy during chronic SIV infection leads to rapid reduction in viral loads and the level of T-cell immune response. Boyer JD; Kumar S; Robinson T; Parkinson R; Wu L; Lewis M; Weiner DB J Med Primatol; 2006 Aug; 35(4-5):202-9. PubMed ID: 16872283 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic dendritic-cell vaccine for simian AIDS. Lu W; Wu X; Lu Y; Guo W; Andrieu JM Nat Med; 2003 Jan; 9(1):27-32. PubMed ID: 12496959 [TBL] [Abstract][Full Text] [Related]
6. Nanochemistry-based immunotherapy for HIV-1. Lori F; Calarota SA; Lisziewicz J Curr Med Chem; 2007; 14(18):1911-9. PubMed ID: 17691933 [TBL] [Abstract][Full Text] [Related]
7. Perspectives on inducing efficient immune control of HIV-1 replication--a new goal for HIV therapeutics? Bucy RP; Kilby JM AIDS; 2001 Feb; 15 Suppl 2():S36-42. PubMed ID: 11424975 [TBL] [Abstract][Full Text] [Related]
8. Tissue-resident macrophages can contain replication-competent virus in antiretroviral-naive, SIV-infected Asian macaques. DiNapoli SR; Ortiz AM; Wu F; Matsuda K; Twigg HL; Hirsch VM; Knox K; Brenchley JM JCI Insight; 2017 Feb; 2(4):e91214. PubMed ID: 28239657 [TBL] [Abstract][Full Text] [Related]
9. DermaVir: a novel topical vaccine for HIV/AIDS. Lisziewicz J; Trocio J; Whitman L; Varga G; Xu J; Bakare N; Erbacher P; Fox C; Woodward R; Markham P; Arya S; Behr JP; Lori F J Invest Dermatol; 2005 Jan; 124(1):160-9. PubMed ID: 15654970 [TBL] [Abstract][Full Text] [Related]